David Matthews
Emeritus Professor of Diabetes Medicine
- Emeritus Founding Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Dean of Degrees and Emeritus Fellow of Harris Manchester College, Oxford
Recent publications
-
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.
Journal article
Avgerinos I. et al, (2021), Diabetes Obes Metab, 23, 822 - 831
-
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.
Journal article
Tsapas A. et al, (2021), Ann Intern Med, 174
-
Early combination therapy delayed treatment escalation in newly diagnosed young-onset type 2 diabetes: A subanalysis of the VERIFY study.
Journal article
Chan JCN. et al, (2021), Diabetes Obes Metab, 23, 245 - 251
-
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
Journal article
Matthews DR. et al, (2020), Diabetes Obes Metab, 22, 2199 - 2203
-
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes.
Journal article
Matthews D. et al, (2020), Diabetes Ther, 11, 2465 - 2476